Meagan C Fitzpatrick

Biographic Data

ID7016285
NAMEMeagan C Fitzpatrick
GIVEN NAMESMeagan C
FAMILY NAMEFitzpatrick
SIGNATUREFITZPATRICK M C
AFFILIATIONSUniversity of Maryland, Baltimore
ORCID0000-0002-5248-2668
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger

    Open AccessBrittany Peterson, William Nguyen et al.ARTICLEPLOS Global Public Health2026

    As programs for azithromycin mass drug administration (AZ-MDA) to reduce child mortality have begun in some parts of West Africa, it is imperative to understand their financial costs. We combined a micro-costing framework and observations from an implementation-focused sub-study within the AVENIR trials in 80 communities in the Dosso region of Niger to estimate the national health sector financial costs of a scaled-up programmatic approach for az…

  • Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger

    Open AccessAhmed M Arzika, Ramatou Maliki et al.ARTICLEPLOS Global Public Health2023

    Recent evidence indicates mass azithromycin distribution reduces under-5 mortality. This intervention is being considered for child survival programs in high mortality sub-Saharan African settings. The delivery approach used in prior studies required a full-time census and distribution team, which is not feasible for most programs. To determine the optimal programmatic approach to delivery, this study aimed to compare treatment coverage, costs, a…

  • Optimizing next-generation RSV prevention in Mali

    Open AccessRachel S Laufer, Ranju Baral et al.ARTICLEPLOS Global Public Health2023

    Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in young children. We analyzed the health and economic impact of RSV …

  • Influenza vaccination should have no border

    Open AccessDan Yamin, Dor Kahana et al.ARTICLEBMC Public Health2021

    Offering influenza vaccination to Palestinians employed in Israel could efficiently reduce morbidity and mortality within both Israel and the Palestinian territory